Complex Control of Vascular Smooth Muscle Cell Growth by Thromboxane A₂

• References

• 1 Grosser T, Zucker T-P, Weber A-A, Schulte K, Sachinidis A, Vetter H, Schrör K. Thromboxane A₂ induces cell signaling but requires platelet-derived growth factor to act as a mitogen.. Eur J Pharmacol 1998; 319: 327-32.
• 2 Zucker T-P, Bönisch D, Muck S, Weber A-A, Bretschneider E, Glusa E, Schrör K. Thrombin-induced mitogenesis in coronary artery smooth muscle cells is potentiated by thromboxane A₂ and involves upregulation of thromboxane receptor mRNA.. Circulation 1998; 97: 589-95.
• 3 Jones DA, Benjamin CW, Linseman DA. Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades.. Mol Pharmacol 1995; 48: 890-6.
• 4 Pakala R, Willerson JT, Benedict CR. Effect of serotonin, thromboxane A₂, and specific receptor antagonists on vascular smooth muscle cell proliferation.. Circulation 1998; 96: 2280-6.
• 5 Muck S, Weber A-A, Meyer-Kirchrath J, Schrör K. The bovine thromboxane A₂ receptor: molecular cloning, expression, and functional characterization.. Naunyn-Schmiedeberg’s Arch Pharmacol 1998; 357: 10-6.